These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32555602)

  • 1. Correction: Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt.
    Ramadan HK; Hassan WA; Elossily NA; Ahmad AA; Mohamed AA; Abd-Elkader AS; Nagiub Abdelsalam EM; Khojah HMJ
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008443. PubMed ID: 32555602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt.
    Ramadan HK; Hassan WA; Elossily NA; Ahmad AA; Mohamed AA; Abd-Elkader AS; Abdelsalam EMN; Khojah HMJ
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007779. PubMed ID: 31553716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt. A preliminary study.
    Hammouda NA; el-Mansoury ST; el-Azzouni MZ; el-Gohari Y
    J Egypt Soc Parasitol; 1995 Apr; 25(1):137-43. PubMed ID: 7602156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.
    Cabada MM; Lopez M; Cruz M; Delgado JR; Hill V; White AC
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004361. PubMed ID: 26808543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human fascioliasis in Egyptian children: successful treatment with triclabendazole.
    el-Karaksy H; Hassanein B; Okasha S; Behairy B; Gadallah I
    J Trop Pediatr; 1999 Jun; 45(3):135-8. PubMed ID: 10401189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triclabendazole for the treatment of fascioliasis and paragonimiasis.
    Keiser J; Engels D; Büscher G; Utzinger J
    Expert Opin Investig Drugs; 2005 Dec; 14(12):1513-26. PubMed ID: 16307491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human fascioliasis: a re-emerging disease in upper Egypt.
    Mekky MA; Tolba M; Abdel-Malek MO; Abbas WA; Zidan M
    Am J Trop Med Hyg; 2015 Jul; 93(1):76-9. PubMed ID: 25870421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human fascioliasis successfully treated with triclabendazole.
    Laird PP; Boray JC
    Aust N Z J Med; 1992 Feb; 22(1):45-7. PubMed ID: 1580862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triclabendazole for the treatment of fascioliasis.
    Thakare R; Dasgupta A; Chopra S
    Drugs Today (Barc); 2019 Dec; 55(12):743-752. PubMed ID: 31942877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of two doses of triclabendazole in treatment of patients with combined schistosomiasis and fascioliasis.
    Osman MM; Shehab AY; Zaki A; Farag HF
    East Mediterr Health J; 2011 Apr; 17(4):266-70. PubMed ID: 22259882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A familial outbreak of fascioliasis in Eastern Anatolia: a report with review of literature.
    Karahocagil MK; Akdeniz H; Sunnetcioglu M; Cicek M; Mete R; Akman N; Ceylan E; Karsen H; Yapici K
    Acta Trop; 2011 Jun; 118(3):177-83. PubMed ID: 18930014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A praziquantel-ineffective fascioliasis case successfully treated with triclabendazole.
    Ishii Y; Nakamura-Uchiyama F; Nawa Y
    Parasitol Int; 2002 Jun; 51(2):205-9. PubMed ID: 12113760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis.
    Talaie H; Emami H; Yadegarinia D; Nava-Ocampo AA; Massoud J; Azmoudeh M; Mas-Coma S
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):777-82. PubMed ID: 15566392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects.
    El-Tantawy WH; Salem HF; Mohammed Safwat NA
    Pharm World Sci; 2007 Jun; 29(3):190-8. PubMed ID: 17265093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on the effect of Bithionol, Praziquantel and Triclabendazole in rabbit's fascioliasis.
    el Sayad MH
    J Egypt Soc Parasitol; 1997 Dec; 27(3):925-6. PubMed ID: 9425836
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response.
    Apt W; Aguilera X; Vega F; Miranda C; Zulantay I; Perez C; Gabor M; Apt P
    Am J Trop Med Hyg; 1995 Jun; 52(6):532-5. PubMed ID: 7611560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Fascioliasis in The Metropolitan Area of Curitiba, Brazil Evaluation of The Foci of Infection and Report of Nine Cases Treated With Triclabendazole.
    Luz JE; Focaccia Siciliano R ; de Oliveira AG; Pisani JC
    Braz J Infect Dis; 1999 Dec; 3(6):220-225. PubMed ID: 11084672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parasite-specific antibody profile in human fascioliasis: application for immunodiagnosis of infection.
    Maher K; El Ridi R; Elhoda AN; El-Ghannam M; Shaheen H; Shaker Z; Hassanein HI
    Am J Trop Med Hyg; 1999 Nov; 61(5):738-42. PubMed ID: 10586905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and efficacy of triclabendazole in goats with induced fascioliasis.
    Kinabo LD; Bogan JA
    J Vet Pharmacol Ther; 1988 Sep; 11(3):254-9. PubMed ID: 3184265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic fascioliasis: case report and review.
    Abdul-Hadi S; Contreras R; Tombazzi C; Alvarez M; Melendez M
    Rev Inst Med Trop Sao Paulo; 1996; 38(1):69-73. PubMed ID: 8762643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.